![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/8/2020 11:37 | Also any share, like SNG, that’s largely got a fragmented PI ownership ( as far as we know....) is likely to get an organised kicking from time to time. Having quality institutions as buyers > £2 is somewhat reassuring, so we wait. | ![]() wetdream | |
27/8/2020 11:34 | It’s the Phase III that can take 6-8months under normal circumstances - Pitched against the competition. However, imho there is no competition for SNG if used correctly (mild/moderate early stage) so what’s to be achieved? Just larger numbers? | ![]() wetdream | |
27/8/2020 11:17 | Thanks.Thought a phase 2 study to test efficacy would take at least 6 to 8 months if not longer. That's what other estimates have been for different C19 related study's that are happening at the moment. | ![]() discodave45 | |
27/8/2020 11:11 | The hospital phase 2 study has been completed and I expect the hone trials to be completed soon as it's been a couple of months since it kicked off. If the COPD results prove positive and safe they may bi-pass phase 3 due to the unprecedented times we're living in (over the last hundred years!). The naturally occurring anti-viral protein is already used albeit a different method of delivery and there are 10s of papers on it which Waterloo on the Guild has unearthed so the evidence is mounting and phase 3 but not be needed or they could have trials without placebo in the US and other countries. Either way only a matter of time before we find out the route and I'm sure it'll be good news for SNG | ![]() tickboo | |
27/8/2020 11:11 | Selling over mid price now, and buying at top of the offer.Should be a tick up as a result. | ![]() festario | |
27/8/2020 11:08 | Looks like a test on low volume. Bodes well. | hodhasharon | |
27/8/2020 11:07 | What are you in at DD45 ?I managed to get in early at 42.35 and now hold the balance at 0 ..... happy Days :)Welcome to SNG thread..... it's a rollercoaster !! | nortic 007 | |
27/8/2020 10:54 | Will phase 2 study be completed late this year / early next? | ![]() discodave45 | |
27/8/2020 10:32 | Trouble is so much is hidden - either trades or Holdings TR1s etc. Been a relatively busy few days, but even so, 90% of shares are just sitting, waiting. Small British Biotechs aren’t ‘meant’ to have major breakthroughs - that’s the preserve of the US... ;-) | ![]() wetdream |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions